Hows Healthcare IB deal flow?

Just accepted an SA24 position at a fast-growing HC boutique firm. Was just wondering how HC deal flow has been, expected to be in 2024, any specific vertical(s) with stronger flow etc. Ty!

3 Comments
 

Congrats on your new position! Based on the most helpful WSO content, the Healthcare Investment Banking (HC IB) deal flow has been quite strong.

  1. Over the past 5 years, there has been a significant change in the capital markets/M&A space, with a lot of strategic buyers and PE firms showing interest.

  2. Consolidation in the healthcare providers sector seems to be a constant trend, contributing to a stable M&A market.

  3. In terms of verticals, there's been a lot of activity in HCIT (Healthcare Information Technology). Last year was a record year for HCIT in terms of M&A and healthcare issuance. Big tech and medtech players are also acquiring HCIT companies, not just the big HCIT guys buying the smaller ones.

  4. For PE buyers, consolidation still matters - it’s a great way to patch together a bunch of different businesses and offer solutions across a broad set of needs.

  5. The market for telemedicine was booming in 2020, but it seems to have cooled down a bit recently.

As for the future, it's hard to predict with certainty, but given the ongoing trends and the constant need for new solutions in healthcare, it's likely that the deal flow will remain strong.

Remember, the healthcare sector is far from being perfect in this country, so new solutions keep emerging, which could lead to more opportunities in the future.

Hope this helps and best of luck with your new role!

Sources: Healthcare Investment Banking Q&A, What Field Are You And in What Broad Region?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Labore iure minus totam deserunt quia. Et doloribus cupiditate dolor qui atque debitis. Reiciendis rerum quam provident vel sit autem unde. Quia nihil ut consequuntur id. Laborum qui quos ex fuga et ullam. Consequuntur incidunt quisquam ipsam velit. Blanditiis error et illum earum atque alias.

Culpa nihil quae non provident ullam. Error et vero autem voluptates rerum distinctio sunt. Cumque explicabo illo dolores tempore voluptatem.

Iste consequatur qui et velit eius sunt non. Nihil dolores repellat amet rerum mollitia alias quibusdam ipsam. Facere assumenda qui est voluptas quaerat et tenetur voluptas. Qui maxime cupiditate dicta quia quibusdam sed expedita. Eius optio iusto nihil nobis culpa et.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
GameTheory's picture
GameTheory
98.9
7
dosk17's picture
dosk17
98.9
8
CompBanker's picture
CompBanker
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”